143 related articles for article (PubMed ID: 12590953)
1. Aprotinin counteracts heparin-induced inhibition of platelet contractile force.
Carr ME; Carr SL; Roa V; McCardell KA; Greilich PE
Thromb Res; 2002 Nov; 108(2-3):161-8. PubMed ID: 12590953
[TBL] [Abstract][Full Text] [Related]
2. Heparin ablates force development during platelet mediated clot retraction.
Carr ME; Carr SL; Greilich PE
Thromb Haemost; 1996 Apr; 75(4):674-8. PubMed ID: 8743198
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass.
Tabuchi N; De Haan J; Boonstra PW; Huet RC; van Oeveren W
Eur J Cardiothorac Surg; 1994; 8(2):87-90. PubMed ID: 7513534
[TBL] [Abstract][Full Text] [Related]
4. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
[TBL] [Abstract][Full Text] [Related]
5. Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery.
Najman DM; Walenga JM; Fareed J; Pifarré R
Ann Thorac Surg; 1993 Mar; 55(3):662-6. PubMed ID: 7680854
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
7. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
[TBL] [Abstract][Full Text] [Related]
9. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
[TBL] [Abstract][Full Text] [Related]
10. Platelet protection in coronary artery surgery: benefits of heparin-coated circuits and high-dose aprotinin therapy.
Wendel HP; Schulze HJ; Heller W; Hoffmeister HM
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):388-92. PubMed ID: 10468249
[TBL] [Abstract][Full Text] [Related]
11. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
Mohr R; Goor DA; Lusky A; Lavee J
Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
[TBL] [Abstract][Full Text] [Related]
12. Reduction of heparin binding to and inhibition of platelets by aprotinin.
John LC; Rees GM; Kovacs IB
Ann Thorac Surg; 1993 May; 55(5):1175-9. PubMed ID: 7684217
[TBL] [Abstract][Full Text] [Related]
13. Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery.
Greilich PE; Brouse CF; Beckham J; Jessen ME; Martin EJ; Carr ME
Thromb Res; 2002 Mar; 105(6):523-9. PubMed ID: 12091054
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood.
Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
Ann Thorac Surg; 1993 Jun; 55(6):1460-6. PubMed ID: 7685588
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
16. Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study.
Lavee J; Savion N; Smolinsky A; Goor DA; Mohr R
Ann Thorac Surg; 1992 Mar; 53(3):477-81. PubMed ID: 1371665
[TBL] [Abstract][Full Text] [Related]
17. The effects of aprotonin on platelets in vitro using whole blood flow cytometry.
Kozek-Langenecker SA; Mohammad SF; Masaki T; Green W; Kamerath C; Cheung AK
Anesth Analg; 2000 Jan; 90(1):12-6. PubMed ID: 10624968
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
Huang H; Ding W; Su Z; Zhang W
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
[TBL] [Abstract][Full Text] [Related]
19. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
20. Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage.
Greilich PE; Carr ME; Carr SL; Chang AS
Anesth Analg; 1995 Mar; 80(3):459-65. PubMed ID: 7864408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
